Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Consecuencias psicosociales de la depresión adolescente
1
x
$
0.00
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
1
x
$
30.00
Farmacoterapias: Lineamientos del concenso de expertos para el tratamiento farmacológico del trastorno bipolar: una nueva herramienta terapéutica
1
x
$
0.00
The Long-Term Efficacy of Radiofrequency Ablation With and Without Steroid Injection
1
x
$
30.00
Duloxetine in Military Posttraumatic Stress Disorder
1
x
$
30.00
Efficacy of Electrical Spinal Cord Stimulation with Neuromodulating Medications: A Systematic Review
1
x
$
30.00
Psychiatric Prescribing Patterns for Depression Treatment in an Outpatient Depression Clinic
1
x
$
30.00
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
1
x
$
0.00
View Cart
Checkout
Home
psychiatric-status-rating-scales
“Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Psychopharmacology Bulletin VOL 47 No. 3, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Page load link
Go to Top
